LCTX
Lineage Cell Therapeutics, Inc.
Recent 8-K filings for LCTX
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 20:10 UTC earnings item 2.02item 9.01
Lineage Q1 2026 net loss $4.8M; cash $53.4M; new COR1 program launched
source · LCTX on sec.gov